Skip to main content
Top
Published in: Diabetologia 8/2020

01-08-2020 | Obesity | Article

Complex interaction of fasting glucose, body mass index, age and sex on all-cause mortality: a cohort study in 15 million Korean adults

Authors: Mi-Hyang Jung, Sang-Wook Yi, Sang Joon An, Beverley Balkau, Jee-Jeon Yi, Hyeongsu Kim

Published in: Diabetologia | Issue 8/2020

Login to get access

Abstract

Aims/hypothesis

The aim of this work was to examine whether synergistic associations with mortality exist for BMI and fasting blood glucose (FBG) and to identify FBG–BMI combined subgroups with higher mortality according to sex and age.

Methods

A total of 15,149,275 Korean adults participated in health examinations during 2003–2006 and were followed up until December 2018. Mortality HRs of 40 FBG–BMI combined groups were assessed by Cox proportional hazards models.

Results

During a mean 13.7 years of follow-up, 1,213,401 individuals died. A J-shaped association was seen between FBG and all-cause mortality for all BMI categories. Those with BMI <20 kg/m2 had the highest mortality for any given FBG level, followed by those with BMI 20–22.4 kg/m2. The detrimental effect of elevated FBG was greater among leaner individuals than more corpulent individuals. Moreover, the synergistic adverse effects of hyperglycaemia and leanness was stronger in younger adults than in older adults. Compared with the reference group (overweight with normoglycaemia), age- and sex-adjusted HRs of the leanest with normoglycaemia (BMI <20 kg/m2 and FBG 4.4–5.2 mmol/l), overweight with diabetes (BMI 25–27.4 kg/m2 and FBG ≥10.0 mmol/l) and leanest with diabetes (BMI <20 kg/m2 and FBG ≥10.0 mmol/l) were 1.29, 2.59 and 11.18, respectively, in those aged 18–44 years and 1.56, 1.72 and 2.87, respectively, in those aged 75–99 years. The identification of BMI–FBG subgroups associated with higher mortality was not straightforward, illustrated by the group with FBG 6.1–6.9 mmol/l and BMI 20–22.4 kg/m2 having a similar or higher mortality compared with the group with FBG 7.0–9.9 mmol/l and BMI ≥22.5 kg/m2. In women aged <45 years with FBG <6.9 mmol/l, those with BMI ≥27.5 kg/m2 had the highest mortality, whereas individuals with BMI <20 kg/m2 had the highest mortality for each given FBG level in other age and sex groups.

Conclusions/interpretation

Leanness and hyperglycaemia interact together to increase mortality in a supra-multiplicative manner, especially in younger adults; the interactions of BMI, FBG, sex and age with mortality are complex.
Appendix
Available only for authorised users
Literature
11.
go back to reference Min WK, Kim KD, Kim SS et al (2004) Annual report on external quality assessment in clinical chemistry in Korea (2003). J Lab Med Qual Assur 26(1):1–10 Min WK, Kim KD, Kim SS et al (2004) Annual report on external quality assessment in clinical chemistry in Korea (2003). J Lab Med Qual Assur 26(1):1–10
Metadata
Title
Complex interaction of fasting glucose, body mass index, age and sex on all-cause mortality: a cohort study in 15 million Korean adults
Authors
Mi-Hyang Jung
Sang-Wook Yi
Sang Joon An
Beverley Balkau
Jee-Jeon Yi
Hyeongsu Kim
Publication date
01-08-2020
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 8/2020
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-020-05160-1

Other articles of this Issue 8/2020

Diabetologia 8/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.